Quratis Inc. (KOSDAQ:348080)
South Korea · Delayed Price · Currency is KRW 946.00
+5.00 (0.53%)
Last updated: Nov 17, 2025, 10:06 AM KST
Quratis Company Description
Quratis Inc. engages in developing vaccines in South Korea.
It is involved in developing QTP101, a vaccine for tuberculosis; dendritic cell-based cell therapy for indications, including cancer, autoimmune, and infectious diseases; and peptide nucleic acid-based antimicrobial agents.
The company also offers drugs contract development and manufacturing services. Quratis Inc. was founded in 2016 and is based in Seoul, South Korea.
Quratis Inc.
| Country | South Korea |
| Founded | 2016 |
| Industry | Biological Products, Except Diagnostic Substances |
Contact Details
Address: Anam Building Seoul, 08375 South Korea | |
| Phone | 82 2 866 0604 |
| Website | quratis.com |
Stock Details
| Ticker Symbol | 348080 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |